Date of Decision: August 16, 2024
Service Center: Nebraska Service Center
Form Type: Form I-140
Case Type: EB-1 Extraordinary Ability
Petitioner Information
Profession: Cardiac Physiologist
Field: Cardiology and Clinical Medicine
Nationality: Indian
Summary of Decision
Initial Decision: Denied
Appeal Outcome: Sustained
Evidentiary Criteria Analysis
Criteria Met:
- Participation as a Judge of the Work of Others:
- The petitioner provided evidence of participation in peer-reviewing scholarly articles in cardiology.
- Original Contributions of Major Significance:
- The petitioner contributed to studies that influenced global clinical practices, including research demonstrating the risks of certain COVID-19 treatments.
- Authorship of Scholarly Articles:
- The petitioner co-authored seven peer-reviewed research papers that have collectively received over 900 citations from doctors and scientists in 55 countries.
Key Points from the Decision
Judging Activities:
The petitioner served as a peer reviewer for cardiology research articles, demonstrating expertise and recognition in his field.
Original Contributions:
- The petitioner’s research on the anti-malarial drug combination of hydroxychloroquine and azithromycin revealed life-threatening risks, influencing global clinical practices during the COVID-19 pandemic.
- He also contributed to studies improving treatment options for severe pulmonary hypertension patients and reducing post-surgical discharge times for patients with cardiac implantable electronic devices (CIEDs).
Authorship and Citations:
- The petitioner’s citation rate places him in the top 1% of authors in the clinical medicine category globally, further establishing his recognition and influence in the field.
Director’s Errors:
- The Director overlooked the significance of the petitioner’s contributions and their widespread impact.
- Although the petitioner did not submit major international award evidence, his work demonstrated sustained national and international acclaim.
Final Merits Determination:
The Administrative Appeals Office (AAO) concluded that the petitioner’s achievements place him among the small percentage at the very top of his field.
Supporting Documentation
Judging Evidence: Peer-review activities for scholarly cardiology journals.
Authorship Evidence: Seven research papers with a high citation rate.
Contribution Evidence: Studies on COVID-19 treatments, LVADs for pulmonary hypertension, and CIED implant discharge protocols.
Conclusion
Final Determination: The appeal was sustained.
Reasoning:
The petitioner met three regulatory criteria under 8 C.F.R. § 204.5(h)(3) and demonstrated sustained national and international acclaim as one of the small percentage at the very top of the field of cardiology.
